CHANNEL THERAPEUTICS CORP (CHRO) Stock Earnings & Estimates
NYSEARCA:CHRO - US1711261057 - Common Stock
1.35 USD
+0.09 (+7.14%)
1.3699 USD
+0.02 (+1.47%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 199.9K | N/A -100.00% | N/A | N/A | N/A | N/A | N/A | |
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.354M | N/A 38.03% | N/A -176.31% | N/A -196.02% | -7.036M -2.53% | -12.087M -71.79% | -15.606M -29.11% | |
| Operating Margin | -677.29% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -1.33 | -1.12 15.38% | -1.07 4.55% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.32 | -0.27 8.55% | -0.26 20.31% |
| Revenue Q2Q % growth | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.32 | -0.21 | -0.11 | -49.39% |
| Q3 2024 Q2Q % growth | -0.29 | -0.23 | -0.06 | -23.61% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |